Filing Details

Accession Number:
0001553878-14-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-23 16:23:57
Reporting Period:
2014-05-21
Filing Date:
2014-05-23
Accepted Time:
2014-05-23 16:23:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178670 Alnylam Pharmaceuticals Inc. ALNY Pharmaceutical Preparations (2834) 770602661
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219015 K John Clarke C/O Cardinal Health Partners
230 Nassau Street
Princeton NJ 08542
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-21 10,000 $7.08 10,000 No 4 M Direct
Common Stock Acquisiton 2014-05-21 10,000 $14.74 20,000 No 4 M Direct
Common Stock Acquisiton 2014-05-21 15,000 $15.91 35,000 No 4 M Direct
Common Stock Disposition 2014-05-21 22,792 $52.95 12,208 No 4 S Direct
Common Stock Disposition 2014-05-21 2,500 $54.21 9,708 No 4 S Direct
Common Stock Disposition 2014-05-21 6,908 $55.47 2,800 No 4 S Direct
Common Stock Disposition 2014-05-21 2,800 $56.19 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2014-05-21 10,000 $0.00 10,000 $7.08
Common Stock Stock Option (Right to Buy) Disposition 2014-05-21 10,000 $0.00 10,000 $14.74
Common Stock Stock Option (Right to Buy) Disposition 2014-05-21 15,000 $0.00 15,000 $15.91
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2006-06-08 2015-06-08 No 4 M Direct
0 2007-06-01 2016-06-01 No 4 M Direct
0 2008-06-01 2017-06-01 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 8,891 Indirect By Managed Account
Footnotes
  1. The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2014.
  2. Sale prices ranged from from $52.50 to $53.48.
  3. Sale prices ranged from from $53.87 to $54.50.
  4. Sale prices ranged from from $54.94 to $55.92.
  5. Sale prices ranged from from $55.94 to $56.62.
  6. These shares are owned by CHP II, L.P. The reporting person is the Managing General Partner of CHP II Management LLC, the General Partner of CHP II L.P. The reporting person may be deemed to beneficially own the shares held by CHP II, L.P. although he disclaims beneficial ownership except to the extent of his proportionate pecuniary interest therein.